Literature DB >> 25372051

PIP4kγ is a substrate for mTORC1 that maintains basal mTORC1 signaling during starvation.

Ashley M Mackey1, Deborah A Sarkes2, Ian Bettencourt2, John M Asara3, Lucia E Rameh4.   

Abstract

Phosphatidylinositol-5-phosphate 4-kinases (PIP4ks) are a family of lipid kinases that specifically use phosphatidylinositol 5-monophosphate (PI-5-P) as a substrate to synthesize phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]. Suppression of PIP4k function in Drosophila results in smaller cells and reduced target of rapamycin complex 1 (TORC1) signaling. We showed that the γ isoform of PIP4k stimulated signaling through mammalian TORC1 (mTORC1). Knockdown of PIP4kγ reduced cell mass in cells in which mTORC1 is constitutively activated by Tsc2 deficiency. In Tsc2 null cells, mTORC1 activation was partially independent of amino acids or glucose and glutamine. PIP4kγ knockdown inhibited the nutrient-independent activation of mTORC1 in Tsc2 knockdown cells and reduced basal mTORC1 signaling in wild-type cells. PIP4kγ was phosphorylated by mTORC1 and associated with the complex. Phosphorylated PIP4kγ was enriched in light microsomal vesicles, whereas the unphosphorylated form was enriched in heavy microsomal vesicles associated with the Golgi. Furthermore, basal mTORC1 signaling was enhanced by overexpression of unphosphorylated wild-type PIP4kγ or a phosphorylation-defective mutant and decreased by overexpression of a phosphorylation-mimetic mutant. Together, these results demonstrate that PIP4kγ and mTORC1 interact in a self-regulated feedback loop to maintain low and tightly regulated mTORC1 activation during starvation.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25372051      PMCID: PMC4579097          DOI: 10.1126/scisignal.2005191

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  50 in total

1.  Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation.

Authors:  L A Serunian; K R Auger; L C Cantley
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation.

Authors:  V D Rao; S Misra; I V Boronenkov; R A Anderson; J H Hurley
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

3.  The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.

Authors:  Ewan M Smith; Stephen G Finn; Andrew R Tee; Gareth J Browne; Christopher G Proud
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

4.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

Authors:  G J Brunn; J Williams; C Sabers; G Wiederrecht; J C Lawrence; R T Abraham
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.

Authors:  M Tiainen; A Ylikorkala; T P Mäkelä
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.

Authors:  M B Yaffe; M Schutkowski; M Shen; X Z Zhou; P T Stukenberg; J U Rahfeld; J Xu; J Kuang; M W Kirschner; G Fischer; L C Cantley; K P Lu
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

7.  A novel phosphatidylinositol-5-phosphate 4-kinase (phosphatidylinositol-phosphate kinase IIgamma) is phosphorylated in the endoplasmic reticulum in response to mitogenic signals.

Authors:  T Itoh; T Ijuin; T Takenawa
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

8.  A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.

Authors:  L E Rameh; K F Tolias; B C Duckworth; L C Cantley
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

9.  The LKB1 tumor suppressor negatively regulates mTOR signaling.

Authors:  Reuben J Shaw; Nabeel Bardeesy; Brendan D Manning; Lyle Lopez; Monica Kosmatka; Ronald A DePinho; Lewis C Cantley
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

Review 10.  PI-loting membrane traffic.

Authors:  Maria Antonietta De Matteis; Anna Godi
Journal:  Nat Cell Biol       Date:  2004-06       Impact factor: 28.824

View more
  16 in total

1.  A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis.

Authors:  Gaurav Sharma; Carlos M Guardia; Ajit Roy; Alex Vassilev; Amra Saric; Lori N Griner; Juan Marugan; Marc Ferrer; Juan S Bonifacino; Melvin L DePamphilis
Journal:  Autophagy       Date:  2019-03-08       Impact factor: 16.016

Review 2.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 3.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

Authors:  Brian K Kennedy; Dudley W Lamming
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

Review 4.  Expanding role of PI5P4Ks in cancer: A promising druggable target.

Authors:  Gurpreet K Arora; Lavinia Palamiuc; Brooke M Emerling
Journal:  FEBS Lett       Date:  2021-12-07       Impact factor: 3.864

5.  Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system.

Authors:  Hyeseok Shim; Chuan Wu; Shivan Ramsamooj; Kaitlyn N Bosch; Zuojia Chen; Brooke M Emerling; Jihye Yun; Hui Liu; Rayman Choo-Wing; Zhiwei Yang; Gerburg M Wulf; Vijay Kumar Kuchroo; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-16       Impact factor: 11.205

6.  Therapeutic Delivery of Pip4k2c-Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart.

Authors:  Ajit Magadum; Neha Singh; Ann Anu Kurian; Mohammad Tofael Kabir Sharkar; Nishat Sultana; Elena Chepurko; Keerat Kaur; Magdalena M Żak; Yoav Hadas; Djamel Lebeche; Susmita Sahoo; Roger Hajjar; Lior Zangi
Journal:  Adv Sci (Weinh)       Date:  2021-03-12       Impact factor: 17.521

7.  Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.

Authors:  Evan K Noch; Isaiah Yim; Teresa A Milner; Lewis C Cantley
Journal:  J Comp Neurol       Date:  2020-06-26       Impact factor: 3.215

8.  Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.

Authors:  Gaoen Ma; Yajian Duan; Xionggao Huang; Cynthia X Qian; Yewlin Chee; Shizuo Mukai; Jing Cui; Arif Samad; Joanne Aiko Matsubara; Andrius Kazlauskas; Patricia A D'Amore; Shuyan Gu; Hetian Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

9.  Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.

Authors:  Lois S Weisman; Juan Botas; Ismael Al-Ramahi; Sai Srinivas Panapakkam Giridharan; Yu-Chi Chen; Samarjit Patnaik; Nathaniel Safren; Junya Hasegawa; Maria de Haro; Amanda K Wagner Gee; Steven A Titus; Hyunkyung Jeong; Jonathan Clarke; Dimitri Krainc; Wei Zheng; Robin F Irvine; Sami Barmada; Marc Ferrer; Noel Southall; Juan Jose Marugan
Journal:  Elife       Date:  2017-12-26       Impact factor: 8.140

Review 10.  Control of diverse subcellular processes by a single multi-functional lipid phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2].

Authors:  Sourav Kolay; Urbashi Basu; Padinjat Raghu
Journal:  Biochem J       Date:  2016-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.